We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Minimally Invasive Surgical Devices Market to Reach USD 28.5 Billion by 2026 Due to Need for Lesser Complications in Surgeries

By HospiMedica International staff writers
Posted on 08 Feb 2022
Print article
Illustration
Illustration

The global minimally invasive surgical devices market is projected to grow at a CAGR of 5.56% from USD 20.93 billion in 2020 to USD 28.54 billion by 2026, driven mainly by the increasing preference for minimally invasive surgeries to avoid physical scar marks and painful recovery, and increasing instances of prolonged & chronic diseases such as cardiovascular diseases, neurological diseases, cancer, etc., where surgeries are a must as a treatment method.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research company.

Minimally invasive devices are technologically advanced and require rather small entry points to enter the human body. Complications of surgeries like cancer removal surgeries, endoscopic surgeries, cardiovascular surgeries, etc. has also increased preference among surgeons for minimally invasive surgeries in order to avoid mistakes, post op-pain for patient, over bleeding, or other complications. Furthermore, increased investment in the healthcare sector, consistent research and development of innovative medical devices by multiple market players are further driving market growth.

However, technological advancements in existing medical devices demands financial and research investments from the market players, and the manufactured medical devices are also required to obtain approvals through clinical trials before being commercialized and utilized for patient treatment, that may restrain market growth.

Based on type, the handheld instruments segment is anticipated to hold the largest revenue share of the minimally invasive surgical devices market and maintain a dominant position on account of increasing demand for precision during surgeries. Moreover, a surge in the demand for technologically-advanced surgical devices like graspers, retractors, and elevators is also expected to support market growth.

Related Links:
Research and Markets 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Cart
UMGSA-33369-VIL

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more